BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global Cardiotoxicity Market – Forecast to 2030,’ thoroughly examines the Cardiotoxicity industry to provide essential data & information for the targeted readers

The latest market analysis report published by Reports and Data, titled ‘Global Acute Conjunctivitis Market – Forecast to 2030,’ thoroughly examines the Acute Conjunctivitis industry to provide essential data & information for the targeted readers

The expansion of the global biopharmaceutical third party logistics market is estimated to be driven by growing trend of outsourcing logistics. In addition, increase in the number of biosimilar launches and emphasis of pharmaceutical companies on their distribution network due to high sales is likely to augur well for the market.

The antibody drug conjugate market is extrapolated to observe stable growth during the forecast period of 2020-2030. High cancer prevalence is one of the major factors which will influence the growth of the antibody drug conjugate market to a considerable extent.

There has been augmented focus on personalized medicines and drug discovery utilizing in vitro methods. In addition, the demand for humanized animal models is also witnessing a rise, which is likely to open plethora of opportunities for the players in the global genetic toxicology testing market in the near future

EvoNexus, California’s leading non-profit tech incubator, selected CRISPR QC to become a portfolio company.

Chicago Pacific Founders is pleased to announce that it, along with Magruder Eye Institute and Robson Eye Institute, has formed Ascend Vision Partners.

Abivax SA, a phase 3 clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, and cancer, announces a transition in the governance of its Board of Directors.

Lotus Bio-Technology Development Corp. (OTC:LBTD) is excited to announce today that the company has begun the process of changing its name from Lotus Bio-Technology Development Corp. to Boomerang Corporation.

Specialty cancer diagnostics company Precipio, Inc., announces the launch of its second generation of HemeScreen panels.